These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15871916)

  • 1. Ion-suppression effects in liquid chromatography-tandem mass spectrometry due to a formulation agent, a case study in drug discovery bioanalysis.
    Larger PJ; Breda M; Fraier D; Hughes H; James CA
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):206-16. PubMed ID: 15871916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery.
    Mei H; Hsieh Y; Nardo C; Xu X; Wang S; Ng K; Korfmacher WA
    Rapid Commun Mass Spectrom; 2003; 17(1):97-103. PubMed ID: 12478560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and reduction of ion suppression effects on pharmacokinetic parameters by polyethylene glycol 400.
    Weaver R; Riley RJ
    Rapid Commun Mass Spectrom; 2006; 20(17):2559-64. PubMed ID: 16878337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays.
    Xu X; Mei H; Wang S; Zhou Q; Wang G; Broske L; Pena A; Korfmacher WA
    Rapid Commun Mass Spectrom; 2005; 19(18):2643-50. PubMed ID: 16124030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'LC-electrolyte effects' improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery.
    Wang L; Sun Y; Du F; Niu W; Lu T; Kan J; Xu F; Yuan K; Qin T; Liu C; Li C
    Rapid Commun Mass Spectrom; 2007; 21(16):2573-84. PubMed ID: 17639570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-column infusion study of the 'dosing vehicle effect' in the liquid chromatography/tandem mass spectrometric analysis of discovery pharmacokinetic samples.
    Shou WZ; Naidong W
    Rapid Commun Mass Spectrom; 2003; 17(6):589-97. PubMed ID: 12621622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving from fast to ballistic gradient in liquid chromatography/tandem mass spectrometry pharmaceutical bioanalysis: Matrix effect and chromatographic evaluations.
    De Nardi C; Bonelli F
    Rapid Commun Mass Spectrom; 2006; 20(18):2709-16. PubMed ID: 16921566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
    Mück W
    Pharmazie; 1999 Sep; 54(9):639-44. PubMed ID: 10522267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
    Hsieh Y
    J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles and applications of LC-MS in new drug discovery.
    Korfmacher WA
    Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isobaric metabolite interferences and the requirement for close examination of raw data in addition to stringent chromatographic separations in liquid chromatography/tandem mass spectrometric analysis of drugs in biological matrix.
    Yan Z; Maher N; Torres R; Cotto C; Hastings B; Dasgupta M; Hyman R; Huebert N; Caldwell GW
    Rapid Commun Mass Spectrom; 2008 Jul; 22(13):2021-8. PubMed ID: 18512848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased productivity in quantitative bioanalysis using a monolithic column coupled with high-flow direct-injection liquid chromatography/tandem mass spectrometry.
    Huang MQ; Mao Y; Jemal M; Arnold M
    Rapid Commun Mass Spectrom; 2006; 20(11):1709-14. PubMed ID: 16676309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation and quantification of two diastereomers of a Drug Candidate in rat plasma by ultra-high pressure liquid chromatography/mass spectrometry.
    Wang H; Edom RW; Kumar S; Vincent S; Shen Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):26-34. PubMed ID: 17442640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for bioanalysis of an oligonucleotide class macromolecule from rat plasma using liquid chromatography-tandem mass spectrometry.
    Zhang G; Lin J; Srinivasan K; Kavetskaia O; Duncan JN
    Anal Chem; 2007 May; 79(9):3416-24. PubMed ID: 17394287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
    Wan H; Rehngren M
    J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing an ultrafast generic high-performance liquid chromatography/tandem mass spectrometry method for faster discovery pharmacokinetic sample throughput.
    Dunn-Meynell KW; Wainhaus S; Korfmacher WA
    Rapid Commun Mass Spectrom; 2005; 19(20):2905-10. PubMed ID: 16167360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling matrix effects during development of a liquid chromatographic-electrospray ionisation tandem mass spectrometric analysis of nine basic pharmaceuticals in aqueous environmental samples.
    Van de Steene JC; Mortier KA; Lambert WE
    J Chromatogr A; 2006 Aug; 1123(1):71-81. PubMed ID: 16720025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying, evaluating, and controlling bioanalytical risks resulting from nonuniform matrix ion suppression/enhancement and nonlinear liquid chromatography-mass spectrometry assay response.
    Liu G; Ji QC; Arnold ME
    Anal Chem; 2010 Dec; 82(23):9671-7. PubMed ID: 21038862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing and compensating for matrix effects using atmospheric pressure chemical ionization liquid chromatography-tandem mass spectrometry: analysis of neutral pharmaceuticals in municipal wastewater.
    Zhao X; Metcalfe CD
    Anal Chem; 2008 Mar; 80(6):2010-7. PubMed ID: 18290635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.